Fulcrum Therapeutics Inc. (FULC)
NASDAQ · Healthcare
Fulcrum Therapeutics Inc. Net Income 2020–2025
Fulcrum Therapeutics Inc. annual/quarterly net income history and growth rate from 2020 to 2025. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Fulcrum Therapeutics Inc. net income for the quarter ending September 30, 2025 was -19.6 M, a 9.68% decrease year-over-year.
- Fulcrum Therapeutics Inc. net income for the twelve months ending September 30, 2025 was -3.2 M, a 96.80% decrease year-over-year.
- Fulcrum Therapeutics Inc. annual net income for 2025 was -74.9 M, a 669.97% increase from 2024.
- Fulcrum Therapeutics Inc. annual net income for 2024 was -9.7 M, a 90.01% decrease from 2023.
- Fulcrum Therapeutics Inc. annual net income for 2023 was -97.3 M, a 11.41% decrease from 2022.
- Fulcrum Therapeutics Inc. annual net income for 2022 was -109.9 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Fulcrum Therapeutics Inc. Net Income — FAQ
Fulcrum Therapeutics Inc. (FULC) net income over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is Fulcrum Therapeutics Inc.'s net income?
Fulcrum Therapeutics Inc. (FULC) reported net income of -$75M for fiscal 2025.
Where can I see FULC's net income history?
The chart and table above show Fulcrum Therapeutics Inc.'s net income by year and by quarter, including the growth rate.